Pre-treatment immune biomarkers of pembrolizumab efficacy in patients with glioblastoma treated with standard of care. Therapeutic insights for the aggressive subset of high-grade gliomas (HGG) driven ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results